Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Airway Extubation | 2 | 2017 | 403 | 0.95 | Why? |
| Diet, Protein-Restricted | 1 | 2021 | 80 | 0.86 | Why? |
| Parenteral Nutrition | 3 | 2017 | 184 | 0.80 | Why? |
| Laryngoscopes | 2 | 2017 | 121 | 0.73 | Why? |
| Enteral Nutrition | 3 | 2017 | 320 | 0.72 | Why? |
| Laryngoscopy | 3 | 2017 | 413 | 0.69 | Why? |
| Pneumonia, Aspiration | 1 | 2017 | 69 | 0.65 | Why? |
| Ventilator Weaning | 2 | 2017 | 536 | 0.60 | Why? |
| Coma | 1 | 2017 | 204 | 0.59 | Why? |
| Nutrition Therapy | 2 | 2018 | 285 | 0.56 | Why? |
| Critical Care | 7 | 2021 | 14081 | 0.51 | Why? |
| Respiration, Artificial | 9 | 2021 | 22116 | 0.45 | Why? |
| Pneumonia, Ventilator-Associated | 4 | 2021 | 861 | 0.45 | Why? |
| Critical Illness | 10 | 2021 | 17281 | 0.44 | Why? |
| Nutritional Status | 3 | 2018 | 1403 | 0.43 | Why? |
| Shock | 1 | 2017 | 1868 | 0.40 | Why? |
| Blood Glucose | 2 | 2017 | 3642 | 0.27 | Why? |
| Nutritional Support | 2 | 2018 | 447 | 0.25 | Why? |
| Family | 1 | 2017 | 2909 | 0.25 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2017 | 2963 | 0.22 | Why? |
| Video Recording | 2 | 2017 | 786 | 0.20 | Why? |
| Stress Disorders, Traumatic | 1 | 2020 | 78 | 0.20 | Why? |
| Intensive Care Units | 14 | 2021 | 29594 | 0.20 | Why? |
| Anti-Bacterial Agents | 3 | 2021 | 10083 | 0.19 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.19 | Why? |
| High-Frequency Ventilation | 1 | 2018 | 57 | 0.18 | Why? |
| Interferon beta-1a | 1 | 2021 | 316 | 0.18 | Why? |
| Tracheitis | 1 | 2018 | 43 | 0.18 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.16 | Why? |
| Bronchitis | 1 | 2018 | 146 | 0.16 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.16 | Why? |
| Intubation, Intratracheal | 3 | 2017 | 3962 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.15 | Why? |
| Pneumonia, Pneumococcal | 1 | 2018 | 251 | 0.15 | Why? |
| Carbapenems | 1 | 2018 | 343 | 0.14 | Why? |
| Oxygen Inhalation Therapy | 2 | 2018 | 3629 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.13 | Why? |
| Tidal Volume | 1 | 2016 | 565 | 0.13 | Why? |
| Vasoconstrictor Agents | 1 | 2017 | 714 | 0.13 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.13 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.12 | Why? |
| Grief | 1 | 2017 | 320 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.11 | Why? |
| Immunocompromised Host | 2 | 2018 | 5150 | 0.11 | Why? |
| Depression | 3 | 2021 | 14116 | 0.11 | Why? |
| France | 7 | 2021 | 12074 | 0.11 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.10 | Why? |
| Anxiety | 3 | 2021 | 17311 | 0.10 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.10 | Why? |
| Prospective Studies | 6 | 2018 | 43301 | 0.09 | Why? |
| Positive-Pressure Respiration | 1 | 2016 | 1160 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.09 | Why? |
| Adult | 13 | 2021 | 244371 | 0.08 | Why? |
| Respiratory Insufficiency | 2 | 2018 | 7301 | 0.08 | Why? |
| Humans | 27 | 2021 | 930598 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.08 | Why? |
| Aged | 13 | 2021 | 215776 | 0.08 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Female | 17 | 2021 | 380317 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Personnel, Hospital | 1 | 2017 | 2273 | 0.07 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Physicians | 1 | 2021 | 4214 | 0.06 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Research Design | 1 | 2015 | 5830 | 0.05 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Community Networks | 1 | 2021 | 342 | 0.04 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.04 | Why? |
| Equivalence Trials as Topic | 1 | 2018 | 242 | 0.04 | Why? |
| Critical Care Outcomes | 1 | 2018 | 138 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Dietary Carbohydrates | 1 | 2017 | 64 | 0.04 | Why? |
| Dietary Proteins | 1 | 2017 | 112 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.03 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.03 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2021 | 2324 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2017 | 88759 | 0.03 | Why? |
| Cannula | 1 | 2018 | 750 | 0.03 | Why? |
| beta-Lactamases | 1 | 2018 | 759 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Ventilators, Mechanical | 1 | 2021 | 2193 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2018 | 2329 | 0.02 | Why? |
| Burnout, Professional | 1 | 2021 | 2489 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Adolescent | 1 | 2015 | 86841 | 0.00 | Why? |
| Young Adult | 1 | 2015 | 93724 | 0.00 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.00 | Why? |
Reignier's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(231)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_